Overview
Eli Lilly and Company, headquartered in Indianapolis, Indiana, USA, operates as a global pharmaceutical leader primarily focused on the discovery, development, and marketing of pharmaceutical products. The company specializes in a broad range of therapeutic areas including diabetes, oncology, immunology, and neurology. Key projects of Eli Lilly involve the development of innovative treatments for complex diseases such as Alzheimer’s through their drug Donanemab, and diabetes with drugs like Mounjaro (tirzepatide). Additionally, their robust research and development efforts emphasize advancing a pipeline that addresses unmet medical needs, a strategy supported by substantial investments in both technology and strategic collaborations within the biotech and pharmaceutical sectors. This focus underscores Eli Lilly's commitment to innovation and its role in shaping the future of healthcare.
AI+ Ask Fintel’s AI assistant about Eli Lilly and Company.
Thinking about good questions…
Basic Stats
The Factor Analysis chart (below right) shows a view of Eli Lilly and Company from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | |
| EV | |
| Shares Out. | 896.83 MM |
| Earnings Date | |
| EPS (TTM) | 15.39 |
| Dividend Yield | |
| Ex-Dividend Date | 2025-08-15 |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.04 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | |
| Beta | |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | 0.19 |
| ROE | 1.01 |
| ROIC | 0.24 |
| CROIC | 0.00 |
| OCROIC | 0.19 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | 89.09 /100 |
| Profitability | 77.93 /100 |
| Quality Score | 85.24 /100 |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | |
| Analyst Sentiment | |
| Fund Sentiment | 30.83 /100 |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Eli Lilly and Company is CLP874,775.95. The forecasts range from a low of CLP655,231.49 to a high of CLP1,200,897.31. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Eli Lilly and Company. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2024-08-05 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-08-05 | Guggenheim | Buy | Buy | Maintains |
| 2024-08-14 | Berenberg | Buy | Buy | Maintains |
| 2024-10-31 | Barclays | Overweight | Overweight | Maintains |
| 2024-10-31 | B of A Securities | Buy | Buy | Maintains |
| 2025-08-11 | Deutsche Bank | Buy | Buy | Maintains |
| 2024-09-09 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-08-16 | Guggenheim | Buy | Buy | Maintains |
| 2024-09-16 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-08-27 | Morgan Stanley | Overweight | Overweight | Reiterate |
| 2024-08-19 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-11-15 | Wolfe Research | Outperform | Initiate | |
| 2024-08-09 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-08-09 | BMO Capital | Outperform | Outperform | Maintains |
| 2024-08-09 | B of A Securities | Buy | Buy | Maintains |
| 2024-07-24 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-07-15 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-07-11 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-07-11 | Berenberg | Buy | Buy | Maintains |
| 2024-07-10 | Barclays | Overweight | Overweight | Maintains |
| 2024-07-05 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2024-07-03 | BMO Capital | Outperform | Outperform | Maintains |
| 2024-07-01 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-06-26 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-06-25 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-06-25 | Truist Securities | Buy | Buy | Reiterate |
| 2024-06-24 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2025-01-28 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-01-28 | Citigroup | Buy | Buy | Maintains |
| 2024-06-24 | B of A Securities | Buy | Buy | Maintains |
| 2024-06-24 | Jefferies | Buy | Buy | Maintains |
| 2024-06-20 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-06-17 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-06-12 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-06-11 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-06-07 | Jefferies | Buy | Buy | Maintains |
| 2024-05-14 | Argus Research | Buy | Buy | Maintains |
| 2024-05-01 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-05-01 | BMO Capital | Outperform | Outperform | Maintains |
| 2024-05-01 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
| 2024-05-01 | Truist Securities | Buy | Buy | Maintains |
| 2024-04-30 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-04-18 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-04-15 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-04-11 | Goldman Sachs | Neutral | Neutral | Maintains |
| 2024-04-05 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-04-03 | Erste Group | Hold | Buy | Upgrade |
| 2024-04-02 | Citigroup | Buy | Buy | Maintains |
| 2024-04-01 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-03-22 | Truist Securities | Buy | Buy | Reiterate |
| 2024-03-15 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-03-01 | B of A Securities | Buy | Buy | Maintains |
| 2024-02-21 | DZ Bank | Buy | Hold | Downgrade |
| 2024-02-20 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-02-16 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2024-02-14 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-02-07 | Truist Securities | Buy | Buy | Maintains |
| 2024-02-07 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2024-02-07 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-02-07 | Barclays | Overweight | Overweight | Maintains |
| 2024-02-07 | BMO Capital | Outperform | Outperform | Maintains |
| 2024-02-06 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-02-06 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
| 2024-02-05 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-02-01 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-01-24 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-01-23 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-01-23 | Barclays | Overweight | Overweight | Maintains |
| 2023-12-21 | Daiwa Capital | Buy | Outperform | Downgrade |
| 2023-11-29 | Truist Securities | Buy | Buy | Reiterate |
| 2023-11-20 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-11-17 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-11-15 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-11-09 | Deutsche Bank | Hold | Initiate | |
| 2023-11-08 | JP Morgan | Overweight | Reiterate | |
| 2023-11-03 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2023-10-23 | Citigroup | Buy | Buy | Maintains |
| 2023-10-23 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-10-11 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2023-10-09 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-10-09 | Wells Fargo | Overweight | Overweight | Maintains |
| 2023-10-02 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-09-05 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2023-09-05 | Argus Research | Buy | Buy | Maintains |
| 2023-09-05 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-08-22 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-08-10 | Goldman Sachs | Neutral | Neutral | Maintains |
| 2023-08-09 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-08-09 | Goldman Sachs | Neutral | Neutral | Maintains |
| 2023-08-09 | Barclays | Overweight | Overweight | Maintains |
| 2023-08-09 | JP Morgan | Overweight | Overweight | Maintains |
| 2023-08-09 | BMO Capital | Outperform | Outperform | Maintains |
| 2023-08-09 | Truist Securities | Buy | Buy | Maintains |
| 2023-08-09 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2023-08-09 | Credit Suisse | Outperform | Outperform | Maintains |
| 2023-08-09 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-08-09 | Jefferies | Hold | Buy | Upgrade |
| 2023-08-08 | Wells Fargo | Overweight | Overweight | Maintains |
| 2023-07-28 | JP Morgan | Overweight | Overweight | Maintains |
| 2023-07-26 | Citigroup | Buy | Buy | Maintains |
| 2023-07-21 | Jefferies | Hold | Hold | Maintains |
| 2023-07-21 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2023-07-20 | Truist Securities | Buy | Buy | Maintains |
| 2023-07-17 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-07-14 | HSBC | Buy | Initiate | |
| 2023-07-13 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-07-11 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2023-06-27 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
| 2023-06-27 | Truist Securities | Buy | Buy | Reiterate |
| 2023-06-20 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-05-26 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-05-26 | Wells Fargo | Overweight | Overweight | Maintains |
| 2023-05-24 | B of A Securities | Buy | Buy | Maintains |
| 2023-05-23 | TD Cowen | Outperform | Maintains | |
| 2023-05-22 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-05-15 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2023-05-04 | BMO Capital | Outperform | Maintains | |
| 2023-05-04 | JP Morgan | Overweight | Maintains | |
| 2023-05-04 | Credit Suisse | Outperform | Maintains | |
| 2023-05-01 | SVB Securities | Outperform | Maintains | |
| 2023-05-01 | Barclays | Overweight | Maintains | |
| 2023-04-28 | Cantor Fitzgerald | Overweight | Maintains | |
| 2023-04-28 | JP Morgan | Overweight | Maintains | |
| 2023-04-28 | Morgan Stanley | Overweight | Maintains | |
| 2023-04-28 | Credit Suisse | Outperform | Maintains | |
| 2023-04-28 | Wells Fargo | Overweight | Maintains | |
| 2023-04-14 | Morgan Stanley | Overweight | Maintains | |
| 2023-04-11 | Guggenheim | Buy | Maintains | |
| 2023-04-10 | Morgan Stanley | Overweight | Maintains | |
| 2023-04-03 | Jefferies | Hold | Maintains | |
| 2023-03-13 | Wells Fargo | Equal-Weight | Overweight | Upgrade |
| 2023-03-06 | Jefferies | Hold | Initiate | |
| 2023-03-03 | Citigroup | Buy | Maintains | |
| 2023-03-01 | Morgan Stanley | Overweight | Maintains | |
| 2023-02-16 | Societe Generale | Hold | Sell | Downgrade |
| 2023-02-03 | Wells Fargo | Equal-Weight | Maintains | |
| 2023-02-03 | Morgan Stanley | Overweight | Maintains | |
| 2023-01-03 | Barclays | Overweight | Maintains | |
| 2022-12-16 | SVB Leerink | Outperform | Maintains | |
| 2022-12-15 | UBS | Buy | Maintains | |
| 2022-12-14 | Morgan Stanley | Overweight | Maintains | |
| 2022-12-08 | Wells Fargo | Equal-Weight | Maintains | |
| 2022-12-07 | Guggenheim | Buy | Maintains | |
| 2022-12-06 | Credit Suisse | Outperform | Maintains | |
| 2022-12-06 | Morgan Stanley | Overweight | Maintains | |
| 2022-12-05 | Cowen & Co. | Outperform | Maintains | |
| 2022-11-22 | Berenberg | Buy | Maintains | |
| 2022-11-18 | Credit Suisse | Outperform | Initiate | |
| 2022-11-17 | Morgan Stanley | Overweight | Maintains | |
| 2022-11-08 | Goldman Sachs | Neutral | Maintains | |
| 2022-11-02 | Barclays | Overweight | Maintains | |
| 2022-11-02 | Wells Fargo | Equal-Weight | Maintains | |
| 2022-11-02 | Morgan Stanley | Overweight | Maintains | |
| 2022-11-02 | SVB Leerink | Outperform | Maintains | |
| 2022-10-12 | Morgan Stanley | Overweight | Maintains | |
| 2022-09-22 | UBS | Neutral | Buy | Upgrade |
| 2022-09-07 | Morgan Stanley | Overweight | Maintains | |
| 2022-09-06 | BMO Capital | Outperform | Maintains | |
| 2022-07-08 | Morgan Stanley | Overweight | Maintains | |
| 2022-07-07 | Barclays | Overweight | Maintains | |
| 2022-06-01 | JP Morgan | Overweight | Maintains | |
| 2022-05-23 | SVB Leerink | Outperform | Initiate | |
| 2022-05-02 | Mizuho | Buy | Maintains | |
| 2022-04-29 | Morgan Stanley | Overweight | Maintains | |
| 2022-04-29 | BMO Capital | Outperform | Maintains | |
| 2022-04-29 | Wells Fargo | Equal-Weight | Maintains | |
| 2022-04-12 | Goldman Sachs | Neutral | Maintains | |
| 2022-04-06 | Morgan Stanley | Overweight | Maintains | |
| 2022-02-04 | Morgan Stanley | Overweight | Maintains | |
| 2022-02-04 | Mizuho | Buy | Maintains | |
| 2022-01-24 | Morgan Stanley | Overweight | Maintains | |
| 2022-01-21 | DZ Bank | Hold | Buy | Upgrade |
| 2022-01-04 | Wells Fargo | Equal-Weight | Maintains | |
| 2021-12-20 | Berenberg | Buy | Maintains | |
| 2021-12-20 | Barclays | Overweight | Maintains | |
| 2021-12-17 | Goldman Sachs | Neutral | Initiate | |
| 2021-12-09 | Wells Fargo | Equal-Weight | Initiate | |
| 2021-11-19 | BMO Capital | Outperform | Initiate | |
| 2021-10-11 | Berenberg | Hold | Buy | Upgrade |
| 2021-09-29 | Citigroup | Neutral | Buy | Upgrade |
| 2021-08-30 | Cowen & Co. | Outperform | Maintains | |
| 2021-08-05 | Morgan Stanley | Overweight | Maintains | |
| 2021-08-05 | DZ Bank | Hold | Buy | Upgrade |
| 2021-08-04 | Mizuho | Buy | Maintains | |
| 2021-08-04 | Morgan Stanley | Overweight | Maintains | |
| 2021-07-06 | Barclays | Overweight | Maintains | |
| 2021-07-02 | Truist Securities | Buy | Maintains | |
| 2021-06-24 | Cowen & Co. | Outperform | Maintains | |
| 2021-06-24 | Cantor Fitzgerald | Overweight | Maintains | |
| 2021-06-15 | JP Morgan | Overweight | Maintains | |
| 2021-06-14 | Goldman Sachs | Buy | Maintains | |
| 2021-04-28 | Mizuho | Buy | Maintains | |
| 2021-04-28 | Morgan Stanley | Overweight | Maintains | |
| 2021-04-28 | Barclays | Overweight | Maintains | |
| 2021-03-15 | Truist Securities | Buy | Maintains | |
| 2021-02-12 | Cowen & Co. | Outperform | Maintains | |
| 2021-02-04 | Morgan Stanley | Overweight | Maintains | |
| 2021-02-01 | Mizuho | Buy | Maintains | |
| 2021-02-01 | Truist Securities | Buy | Maintains | |
| 2021-01-22 | B of A Securities | Buy | Maintains | |
| 2021-01-19 | Mizuho | Neutral | Buy | Upgrade |
| 2020-12-10 | Wolfe Research | Peer Perform | Outperform | Upgrade |
| 2020-11-17 | Mizuho | Neutral | Maintains | |
| 2020-11-10 | Bernstein | Market Perform | Initiate | |
| 2020-10-28 | Morgan Stanley | Overweight | Maintains | |
| 2020-10-23 | Truist Securities | Buy | Initiate | |
| 2020-10-16 | JP Morgan | Overweight | Maintains | |
| 2020-09-29 | Berenberg | Hold | Initiate | |
| 2020-09-03 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2020-08-14 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-06-17 | JP Morgan | Overweight | Maintains | |
| 2020-04-24 | CFRA | Hold | Maintains | |
| 2020-04-21 | UBS | Buy | Neutral | Downgrade |
| 2020-04-15 | Cowen & Co. | Outperform | Maintains | |
| 2020-04-09 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
| 2020-04-02 | Morgan Stanley | Overweight | Maintains | |
| 2020-03-11 | Goldman Sachs | Buy | Maintains | |
| 2020-02-06 | Mizuho | Neutral | Initiate | |
| 2019-12-30 | Argus Research | Buy | Maintains | |
| 2019-12-18 | JP Morgan | Overweight | Maintains | |
| 2019-12-18 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2019-10-17 | UBS | Buy | Maintains | |
| 2019-09-10 | Bank of America | Neutral | Reiterate | |
| 2019-05-28 | Goldman Sachs | Buy | Initiate | |
| 2019-05-01 | BMO Capital | Outperform | Outperform | Maintains |
| 2019-04-24 | Edward Jones | Hold | Buy | Upgrade |
| 2019-04-11 | Guggenheim | Buy | Neutral | Downgrade |
| 2019-01-23 | UBS | Buy | Initiate | |
| 2018-11-26 | Citigroup | Buy | Neutral | Downgrade |
| 2018-10-31 | Credit Suisse | Underperform | Neutral | Upgrade |
| 2018-10-24 | Wolfe Research | Peer Perform | Initiate | |
| 2018-10-12 | Barclays | Overweight | Overweight | Maintains |
| 2018-10-05 | BMO Capital | Market Perform | Outperform | Upgrade |
| 2018-10-03 | BMO Capital | Market Perform | Market Perform | Maintains |
| 2018-09-18 | Barclays | Overweight | Overweight | Maintains |
| 2018-09-07 | Barclays | Overweight | Overweight | Maintains |
| 2018-07-31 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2018-07-25 | Credit Suisse | Underperform | Underperform | Maintains |
| 2018-07-25 | Berenberg | Buy | Hold | Downgrade |
| 2018-07-25 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
| 2018-07-25 | Bank of America | Neutral | Neutral | Maintains |
| 2018-07-25 | BMO Capital | Market Perform | Market Perform | Maintains |
| 2018-07-19 | BMO Capital | Market Perform | Market Perform | Maintains |
| 2018-07-17 | Bank of America | Neutral | Neutral | Maintains |
| 2018-06-22 | DZ Bank | Buy | Hold | Downgrade |
| 2018-06-21 | Credit Suisse | Underperform | Underperform | Maintains |
| 2018-06-08 | Cantor Fitzgerald | Overweight | Initiate | |
| 2018-04-25 | BMO Capital | Market Perform | Market Perform | Maintains |
| 2018-04-13 | BMO Capital | Underperform | Market Perform | Upgrade |
| 2018-02-01 | BMO Capital | Underperform | Underperform | Maintains |
| 2018-02-01 | Bank of America | Neutral | Neutral | Maintains |
| 2018-01-22 | Credit Suisse | Neutral | Underperform | Downgrade |
| 2018-01-16 | Goldman Sachs | Buy | Neutral | Downgrade |
| 2018-01-05 | Argus | Hold | Buy | Upgrade |
| 2017-11-21 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2017-10-23 | Leerink Swann | Market Perform | Maintains | |
| 2017-10-13 | Barclays | Overweight | Maintains | |
| 2017-10-10 | BMO Capital | Underperform | Maintains | |
| 2017-10-10 | Credit Suisse | Outperform | Neutral | Downgrade |
| 2017-09-15 | Jefferies | Buy | Maintains | |
| 2017-09-06 | BMO Capital | Underperform | Maintains | |
| 2017-07-26 | Leerink Swann | Outperform | Market Perform | Downgrade |
| 2017-07-17 | Deutsche Bank | Buy | Maintains | |
| 2017-07-17 | Jefferies | Buy | Maintains | |
| 2017-04-27 | Argus | Buy | Hold | Downgrade |
| 2017-04-17 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
| 2017-04-17 | BMO Capital | Market Perform | Underperform | Downgrade |
| 2016-12-16 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2016-11-25 | Atlantic Equities | Overweight | Neutral | Downgrade |
| 2016-11-25 | BMO Capital | Outperform | Market Perform | Downgrade |
| 2016-09-27 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2016-09-08 | JP Morgan | Overweight | Maintains | |
| 2016-08-02 | Argus | Buy | Maintains | |
| 2016-08-02 | Argus Research | Buy | Maintains | |
| 2016-07-14 | Jefferies | Buy | Maintains | |
| 2016-05-02 | Leerink Swann | Outperform | Maintains | |
| 2016-05-01 | Credit Suisse | Outperform | Maintains | |
| 2016-04-06 | Societe Generale | Hold | Initiate | |
| 2016-03-15 | Jefferies | Buy | Maintains | |
| 2015-12-28 | Leerink Swann | Outperform | Maintains | |
| 2015-12-18 | Atlantic Equities | Overweight | Initiate | |
| 2015-12-07 | Deutsche Bank | Hold | Buy | Upgrade |
| 2015-12-01 | Barclays | Equal-Weight | Overweight | Upgrade |
| 2015-11-16 | BMO Capital | Market Perform | Outperform | Upgrade |
| 2015-10-13 | Leerink Swann | Outperform | Maintains | |
| 2015-10-09 | Credit Suisse | Neutral | Outperform | Upgrade |
| 2015-09-21 | JP Morgan | Neutral | Maintains | |
| 2015-09-18 | Jefferies | Buy | Maintains | |
| 2015-08-27 | Berenberg | Buy | Initiate | |
| 2015-08-07 | Jefferies | Buy | Maintains | |
| 2015-07-27 | SunTrust Robinson Humphrey | Buy | Maintains | |
| 2015-07-27 | Leerink Swann | Outperform | Maintains | |
| 2015-07-22 | Barclays | Equal-Weight | Maintains | |
| 2015-07-15 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
| 2015-07-13 | Jefferies | Buy | Maintains | |
| 2015-06-26 | Leerink Swann | Outperform | Maintains | |
| 2015-06-25 | Bank of America | Neutral | Buy | Upgrade |
| 2015-06-18 | Argus | Buy | Maintains | |
| 2015-06-18 | Argus Research | Buy | Maintains | |
| 2015-06-17 | PiperJaffray | Overweight | Initiate | |
| 2015-04-29 | Citigroup | Neutral | Buy | Upgrade |
| 2015-04-24 | BMO Capital | Market Perform | Maintains | |
| 2015-03-25 | SunTrust Robinson Humphrey | Buy | Maintains | |
| 2015-03-13 | Leerink Swann | Outperform | Maintains | |
| 2015-02-20 | Jefferies | Buy | Maintains | |
| 2015-02-02 | JP Morgan | Neutral | Maintains | |
| 2015-01-16 | Barclays | Equal-Weight | Maintains | |
| 2015-01-15 | Goldman Sachs | Sell | Neutral | Upgrade |
| 2015-01-09 | Bank of America | Buy | Neutral | Downgrade |
| 2015-01-08 | Jefferies | Hold | Buy | Upgrade |
| 2015-01-08 | Deutsche Bank | Buy | Hold | Downgrade |
| 2014-12-11 | Morgan Stanley | Underweight | Overweight | Upgrade |
| 2014-12-04 | Jefferies | Hold | Maintains | |
| 2014-10-27 | Argus | Buy | Maintains | |
| 2014-10-27 | Argus Research | Buy | Maintains | |
| 2014-10-13 | Jefferies | Hold | Maintains | |
| 2014-10-02 | Guggenheim | Buy | Initiate | |
| 2014-08-27 | Deutsche Bank | Buy | Initiate | |
| 2014-08-11 | Jefferies | Hold | Maintains | |
| 2014-08-01 | Tigress Financial | Buy | Initiate | |
| 2014-07-31 | Citigroup | Buy | Neutral | Downgrade |
| 2014-07-29 | Argus | Buy | Maintains | |
| 2014-07-29 | Argus Research | Buy | Maintains | |
| 2014-07-14 | Jefferies | Hold | Maintains | |
| 2014-07-02 | Barclays | Underweight | Equal-weight | Upgrade |
| 2014-04-29 | Argus | Buy | Maintains | |
| 2014-04-29 | Argus Research | Buy | Maintains | |
| 2014-04-28 | Leerink Swann | Outperform | Maintains | |
| 2014-04-23 | MKM Partners | Buy | Neutral | Downgrade |
| 2014-04-14 | Jefferies | Hold | Maintains | |
| 2014-04-08 | BMO Capital | Underperform | Market Perform | Upgrade |
| 2014-04-03 | Cowen & Co. | Market Perform | Outperform | Upgrade |
| 2014-04-01 | Bank of America | Buy | Maintains | |
| 2014-01-10 | Barclays | Equal-weight | Underweight | Downgrade |
| 2014-01-08 | BMO Capital | Market Perform | Underperform | Downgrade |
| 2013-11-11 | Goldman Sachs | Neutral | Sell | Downgrade |
| 2013-10-24 | MKM Partners | Neutral | Buy | Upgrade |
| 2013-10-11 | Jefferies | Hold | Underperform | Downgrade |
| 2013-10-10 | Edward Jones | Hold | Sell | Upgrade |
| 2013-10-08 | Credit Suisse | Neutral | Initiate | |
| 2013-07-25 | Barclays | Equal-Weight | Maintains | |
| 2013-05-29 | SunTrust Robinson Humphrey | Buy | Initiate | |
| 2013-05-28 | Jefferies | Underperform | Hold | Upgrade |
| 2013-04-10 | Jefferies | Underperform | Maintains | |
| 2013-01-30 | UBS | Neutral | Maintains | |
| 2013-01-30 | Goldman Sachs | Neutral | Maintains | |
| 2013-01-30 | Citigroup | Buy | Maintains | |
| 2013-01-30 | Barclays | Equal-Weight | Maintains | |
| 2013-01-17 | CLSA | Sell | Initiate | |
| 2013-01-16 | Jefferies | Underperform | Maintains | |
| 2013-01-09 | Bank of America | Buy | Maintains | |
| 2013-01-07 | Barclays | Equal-Weight | Maintains | |
| 2013-01-07 | UBS | Neutral | Maintains | |
| 2012-11-30 | Citigroup | Buy | Initiate | |
| 2012-11-29 | Citigroup | Buy | Maintains | |
| 2012-10-26 | BMO Capital | Market Perform | Maintains | |
| 2012-10-15 | Leerink Swann | Market Perform | Outperform | Upgrade |
| 2012-10-12 | Cowen & Co. | Neutral | Underperform | Downgrade |
| 2012-10-12 | Jefferies | Underperform | Maintains | |
| 2012-10-11 | Bank of America | Buy | Maintains | |
| 2012-10-09 | UBS | Neutral | Maintains | |
| 2012-10-09 | Goldman Sachs | Sell | Neutral | Upgrade |
| 2012-09-21 | UBS | Neutral | Maintains | |
| 2012-09-14 | Goldman Sachs | Sell | Maintains | |
| 2012-09-05 | Bernstein | Market Perform | Outperform | Upgrade |
| 2012-08-29 | Bank of America | Buy | Maintains | |
| 2012-08-28 | Atlantic Equities | Underweight | Overweight | Upgrade |
| 2012-08-24 | Credit Suisse | Neutral | Outperform | Upgrade |
| 2012-07-30 | Jefferies | Hold | Underperform | Downgrade |
| 2012-07-27 | Morgan Stanley | Underweight | Maintains | |
| 2012-07-18 | Morgan Stanley | Underweight | Maintains | |
| 2012-07-13 | Jefferies | Hold | Maintains | |
| 2012-06-27 | Goldman Sachs | Sell | Maintains | |
| 2012-05-18 | BMO Capital | Market Perform | Initiate | |
| 2012-05-07 | Bank oferica | Buy | Maintains | |
| 2024-10-25 | Citigroup | Buy | Buy | Maintains |
| 2024-10-03 | Deutsche Bank | Buy | Buy | Reiterate |
| 2024-10-17 | Bernstein | Outperform | Initiate | |
| 2025-03-05 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-09-13 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-09-13 | Citigroup | Buy | Buy | Reiterate |
| 2024-11-04 | Deutsche Bank | Buy | Buy | Maintains |
| 2025-07-11 | Guggenheim | Buy | Buy | Maintains |
| 2025-02-03 | Truist Securities | Buy | Buy | Maintains |
| 2024-08-12 | Deutsche Bank | Hold | Buy | Upgrade |
| 2024-12-10 | B of A Securities | Buy | Reiterate | |
| 2024-10-10 | Truist Securities | Buy | Buy | Maintains |
| 2025-05-02 | UBS | Buy | Buy | Maintains |
| 2025-04-08 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2025-06-20 | Guggenheim | Buy | Buy | Reiterate |
| 2025-04-09 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2025-08-27 | HSBC | Reduce | Hold | Upgrade |
| 2025-04-14 | Guggenheim | Buy | Buy | Maintains |
| 2025-07-10 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2025-08-08 | UBS | Buy | Buy | Maintains |
| 2025-04-22 | Cantor Fitzgerald | Overweight | Initiate | |
| 2025-04-28 | HSBC | Buy | Reduce | Downgrade |
| 2025-08-13 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
| 2025-08-13 | Guggenheim | Buy | Buy | Maintains |
